Literature DB >> 18579156

A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis.

Kazuma Nakagawa1, Sarah I Sheikh, Matija Snuderl, Matthew P Frosch, Steven M Greenberg.   

Abstract

Leptomeningeal amyloidosis is a rare central nervous system manifestation of systemic amyloidosis from transthyretin (TTR) mutation. Ten TTR gene mutations associated with this condition have been described. We report the clinical, radiological, and pathological features of a case of leptomeningeal amyloidosis from a novel Thr49Pro TTR gene mutation. A 53 year-old man presented with recurrent episodes of transient aphasia and right hand stiffness, headaches, and peripheral neuropathy. A surgical biopsy of the leptomeninges and superficial cortex, and DNA sequences of the TTR gene were analyzed. Elevated cerebrospinal fluid (CSF) protein and diffuse leptomeningeal enhancement of the neuraxis from the cortical sulci to the cauda equina on contrast MRI were the defining clinical features. A surgical biopsy revealed TTR amyloid deposition in the subpia and within the leptomeningeal blood vessels. DNA sequencing showed a proline-for-threonine substitution at codon 49 of the TTR gene in one allele. A novel Thr49Pro TTR gene mutation is associated with leptomeningeal amyloidosis resulting in recurrent CNS symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579156     DOI: 10.1016/j.jns.2008.05.014

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

Review 1.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

2.  The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis.

Authors:  Kuan Fan; Haixia Zhu; Hongbo Xu; Ping Mao; Lamei Yuan; Hao Deng
Journal:  J Neurol       Date:  2018-11-23       Impact factor: 4.849

3.  Does transthyretin function as one of contributors for preeclampsia?

Authors:  Yuxuan Chen; Zhenyu Zhang
Journal:  Med Hypotheses       Date:  2010-09-09       Impact factor: 1.538

Review 4.  Amyloidosis in Heart Failure.

Authors:  Sandra Ihne; Caroline Morbach; Laura Obici; Giovanni Palladini; Stefan Störk
Journal:  Curr Heart Fail Rep       Date:  2019-12

5.  Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.

Authors:  Nelson Ferreira; Maria João Saraiva; Maria Rosário Almeida
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

6.  Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis.

Authors:  E P Azevedo; J H Ledo; G Barbosa; M Sobrinho; L Diniz; A C C Fonseca; F Gomes; L Romão; F R S Lima; F L Palhano; S T Ferreira; D Foguel
Journal:  Cell Death Dis       Date:  2013-09-05       Impact factor: 8.469

7.  Mobile and cordless telephones, serum transthyretin and the blood-cerebrospinal fluid barrier: a cross-sectional study.

Authors:  Fredrik Söderqvist; Michael Carlberg; Lennart Hardell
Journal:  Environ Health       Date:  2009-04-21       Impact factor: 5.984

8.  Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia.

Authors:  Jennifer L Ziskin; Michael D Greicius; Wan Zhu; Anna N Okumu; Christopher M Adams; Edward D Plowey
Journal:  Acta Neuropathol Commun       Date:  2015-07-10       Impact factor: 7.801

9.  Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.

Authors:  P McColgan; S Viegas; S Gandhi; K Bull; R Tudor; F Sheikh; J Pinney; M Fontana; D Rowczenio; J D Gillmore; J A Gilbertson; C J Whelan; S Shah; Z Jaunmuktane; J L Holton; J M Schott; D J Werring; P N Hawkins; M M Reilly
Journal:  J Neurol       Date:  2014-12-09       Impact factor: 4.849

Review 10.  Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting.

Authors:  Robert Kisilevsky; Sara Raimondi; Vittorio Bellotti
Journal:  Front Mol Biosci       Date:  2016-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.